Scientific Programme - Unaccredited | Société Internationale d'Urologie

SIU 2022 - Scientific Programme - Unaccredited*

*SUBJECT TO CHANGE

All session times are listed in Eastern Time (ET).

To view the PDF version of the Scientific Programme, please click here.

Wednesday, November 09

Please click on the session titles to view the session details when available.

Session will be available live and/or on-demand on [email protected]

0800-1000

SYMP-02: Symposium: Arab Urology Around the World (AAU)

Room: 518 B
Chair: Raed Azhar, Saudi Arabia
Moderators: Saad Aldousari, Kuwait / Murilo Luz, Brazil

0800-1200

SYMP-03: Symposium: Joint Colegio Mexicano de Urología (CMU) & Sociedad Mexicana de Urologia (SMU) (in Spanish/En español)

Room: 518 C
Co-Chairs: José Gadú Campos Salcedo, Mexico / Héctor Raúl Vargas Zamora, Mexico

0800-1700

SYMP-04: Symposium: World Urological Oncology Federation (WUOF)

Room: 524 AB
Speaker: Sam Spigelman
Co-Chairs: Peter Hammerer, Germany / Laurence Klotz, Canada

0900-1200

SYMP-01: Symposium: 10th Symposium on Affordable New Technologies in Urology (SANTU) and 5th Best Affordable New Technologies in Urology Contest (BANTUC)

Room: 518 A
Chair: Mohammed Lezrek, Morocco
Co-Chair: Arvind Ganpule, India
Honorary Chair: Daniel Yachia, Israel

1000-1200

SYMP-05: Symposium: Joint SIU / SAARC Association of Urological Surgeons (SAUS)

Room: 518 B
Co-Chairs: Madhu Sudan Agrawal, India / Pawan R Chalise, Nepal

1250-1700

SYMP-06: Symposium: Joint SIU / Chinese Urological Association (CUA)

Room: 518 A
Co-Chairs: Patrick Coloby, France / Xiaoping Zhang, China

1300-1700

SYMP-07: Symposium: Indian Urology Around the World (USI)

Room: 518 B

1300-1500

SYMP-08: Symposium: Joint Kenya Association of Urological Surgeons (KAUS) and South African Urological Association (SAUA)

Room: 518 C
Co-Chairs: Shingai Mutambirwa, South Africa / Saeed R. Samnakay, Kenya

1500-1700

SYMP-09: Symposium: Pan-African Urological Surgeons Association (PAUSA)

Room: 518 C
Chairs: Emmanuel Abara, Canada / E. Oluwabunmi Olapade-Olaopa, Nigeria
Co-Chairs: Shingai Mutambirwa, South Africa / Medina Ndoye, Senegal

Thursday, November 10

Please click on the session titles to view the session details when available.

Session will be available live and/or on-demand on [email protected]

1700-1800		OC: Opening Ceremony Room: 517 A
1815-1945		Exhibit Hall - Welcome Reception Room: Exhibit Hall 517 CD

Friday, November 11

Please click on the session titles to view the session details when available.

Session will be available live and/or on-demand on [email protected]

0930-1700		Exhibit Hall Room: Exhibit Hall 517 CD
1030-1050		SS-01: Studio Session: Bench-to-Bedside Uro-Oncology: Clinical Trial Spotlight on EV-302/EV-103 Cohort K: A Novel Treatment Approach for Advanced Urothelial Carcinoma? Room: [email protected] Studio
		Faculty: Srikala Sridhar, Canada Peter Black, Canada This Clinical Trial Spotlight session will summarize key insights from emerging data from EV-103 cohort K and the ongoing EV-302 trial. During this session, Dr. Srikala Sridhar will be interviewed by Dr. Peter Black about the recent data from cohort K in EV-103, how these inform the phase 3 EV-302, and what implications the results of both trials may have for the treatment landscape of advanced urothelial carcinoma.
1730-1815		SS-02: Studio Session: Bench-to-Bedside Uro-Oncology: GU Cancers Triad Meeting - Experts Highlights Room: [email protected] Studio
		Moderators: Peter Black / Simon Tanguay, Canada Panelists: Eugene Pietzak, United States Lori Wood, Canada Martin Gleave, Canada During this experts’ highlights discussion moderated by Drs. Peter Black and Simon Tanguay, the invited faculty will summarize key developments in the management of bladder, kidney, and prostate cancers discussed during the 4th edition of the B2B Uro-Oncology: GU Cancers Triad Meeting. Our expert panel will provide guidance to the urological community on how to best incorporate advancements in the field into practice within a multidisciplinary setting, with the aims of improving treatment outcomes and patient care.
1730-1830		SYMP-24: Symposium: Individualized Care for LUTS/BPE Patients in the Digital Era Room: 519 A
		Chair: Dean Elterman, Canada Panelists: Stavros Gravas, Cyprus Claus Roehrborn, United States Welcome and Objectves Dean Elterman Pharmacological Treatment in Individual Profiles Claus Roehrborn Mobile Health Apps: Enhancing the Management in Individual Patients Stavros Gravas Future Directions – A Panel Discussion Moderated by Dean Elterman Take-home Messages Dean Elterman

Saturday, November 12

Please click on the session titles to view the session details when available.

Session will be available live and/or on-demand on [email protected]

0930-1700		Exhibit Hall Room: Exhibit Hall 517 CD
1700-1730		SS-03: Studio Session: Bench-to-Bedside Uro-Oncology: Clinical Trial Spotlight on CheckMate 274: Insights from Extended Follow-Up and Patient Quality of Life Room: [email protected] Studio
		Faculty: Matthew Galsky, United States Wassim Kassouf, Canada This Clinical Trial Spotlight will summarize the key insights from emerging data from CheckMate 274. During this session, Dr. Matthew Galsky will be interviewed by Dr. Wassim Kassouf about the implications of the CheckMate 274 trial and provide guidance to the urological community on whether the extended follow-up and HR-QoL data from CheckMate 274 support adjuvant nivolumab therapy as a new standard of care in muscle-invasive urothelial carcinoma (MIUC).